FDA: Medtronic missed epilepsy device study goal

Last Updated: 2010-03-10 18:00:01 -0400 (Reuters Health)

WASHINGTON (Reuters) - Medtronic Inc missed the main effectiveness goal in a study testing an approved brain device for treatment of epilepsy, U.S. device reviewers said in documents prepared for an advisory panel.  (More)